Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial
Citations
2,382 citations
Cites background or methods from "Perioperative FOLFOX4 chemotherapy ..."
...The preferred treatment in this setting should be FOLFOX [or alternatively capecitabine with oxaliplatin (CAPOX)] as reported for the EPOC trial [163, 164]....
[...]
...In the case of ‘fit’ patients with initially resectable metastatic disease, the recommendation is (Recommendation 12 this document) that they can either be referred immediately for potentially curative surgery or for perioperative chemotherapy (FOLFOX) [163, 164], dependent on the available prognostic information and surgical considerations....
[...]
...The panel expressed no clear preference for one option over the other, since the 5-year OS rate reported for the EPOC study with perioperative chemotherapy, 51% (95% CI 45–58) in the perioperative chemotherapy group versus 48% (95% CI 40– 55) in the surgery-only group, is not convincing, despite the fact that the DFS in eligible patients was significantly improved [163]....
[...]
1,709 citations
954 citations
589 citations
469 citations
Additional excerpts
...Complications, z mean (SD), $ (n 1⁄414 LLR/ n1⁄419 OLR) 3,174 (3,345) 6,771 (8,716) 3,597 0....
[...]
...954 Complications, z mean (SD), $ 419 (1,603) 735 (3,491) 316 0....
[...]
...Surgical ward, mean (SD), $ 5,371 (2,855) 3,973 (3,725) -1,398 0....
[...]
References
52,450 citations
4,469 citations
3,738 citations
1,910 citations
1,741 citations